ArticleCytotherapy2019

Epstein-Barr Virus (EBV)-derived BARF1 encodes CD4- and CD8-restricted epitopes as targets for T-cell immunotherapy.

Mamta Kalra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.